•Abstract• Objective: To report efficacy of transarterial Onyx embolization of dural arteriovenous fistulas (DAVFs) previously treated with N-butyl cyanoacrylate (NBCA). Two cases are presented with special considerations given to the technical and anatomical aspects based on operative findings. Case Presentation: Superior petrosal and tentorial DAVFs presented with tinnitus and cortical venous reflux, headache with decreased cognitive function respectively. The DAVFs were initially treated with multiple injections of NBCA ending in persistently remaining fistula, subsequently leading to recurrence. Transarterial Onyx embolization was performed, resulting in penetration of Onyx into the complex vascular network and draining veins, with retrograde filling of multiple feeding arteries. The affected sinus was preserved. Conclusion: With the potential of better penetration of Onyx, transarterial Onyx embolization may be capable of treating recurrent NBCAtreated DAVFs. Larger number of cases and longer follow-up are required to determine the efficacy and safety of transarterial Onyx embolization of DAVFs.
Introduction

Total occlusion of dural arteriovenous fistulas (DAVFs)
via transarterial embolization is difficult due to the rich anastomotic network of the dural/falcine plethora of feeding arteries, blood supply to cranial nerves, and extracranial to intracranial anastomoses. Incomplete occlusion of the fistulas will result in recanalization of the DAVF from the multiple collateral arteries constituting the dural blood supply.
Transvenous occlusion or surgical skeletonization of true sinus or resection of the affected venous sinus has been reported effective in selected cases 5, 12, 13) . However, these treatments can be hazardous when the venous sinus drains cortical or deep veins. When total occlusion of a DAVF is difficult, surgical or endovascular selective disconnection of cortical venous reflux to control the disease is reported effective in DAVFs with combined sinus drainage and cortical venous reflux 15) . Onyx (ev3, Irvine, CA, USA) is a new liquid embolic agent with longer precipitation time enabling prolonged injection time, with potential of better penetration into a fistulous network. Previous reports have described initial successful transarterial Onyx embolization of DAVF as a primary treatment 1, 3, 6, 9, 11, 14) . In our report, we present successful Onyx DAVF embolization in recurrent DAVFs previously treated with N-butyl cyanoacrylate (NBCA). Focus is given on the technique and anatomical considerations of transarterial DAVF Onyx embolization based on intraprocedural findings. (Fig. 1B, C) . Angiogram showed complete occlusion of the DAVF (Fig. 1D) (Fig. 2E) . The embolization resulted in significant decrease in the arteriovenous shunt, preserving the vein of Galen (Fig. 2F, G) . Advances in delivery catheters with detachable tips, proximal control, or other forms to obtain control in forward delivery of Onyx are forthcoming, which will further add to its safety and reliability. 
